Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species.
Although misfolding of normal prion protein (PrPC) into abnormal conformers (PrPSc) is critical for prion disease pathogenesis our current understanding of the underlying molecular pathophysiology is rudimentary. Exploiting an electrophysiology paradigm, herein we report that at least modestly prote...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-08-01
|
| Series: | PLoS Pathogens |
| Online Access: | http://europepmc.org/articles/PMC6101418?pdf=render |
| _version_ | 1818864061489610752 |
|---|---|
| author | Simote Totauhelotu Foliaki Victoria Lewis David Isaac Finkelstein Victoria Lawson Harold Arthur Coleman Matteo Senesi Abu Mohammed Taufiqual Islam Feng Chen Shannon Sarros Blaine Roberts Paul Anthony Adlard Steven John Collins |
| author_facet | Simote Totauhelotu Foliaki Victoria Lewis David Isaac Finkelstein Victoria Lawson Harold Arthur Coleman Matteo Senesi Abu Mohammed Taufiqual Islam Feng Chen Shannon Sarros Blaine Roberts Paul Anthony Adlard Steven John Collins |
| author_sort | Simote Totauhelotu Foliaki |
| collection | DOAJ |
| description | Although misfolding of normal prion protein (PrPC) into abnormal conformers (PrPSc) is critical for prion disease pathogenesis our current understanding of the underlying molecular pathophysiology is rudimentary. Exploiting an electrophysiology paradigm, herein we report that at least modestly proteinase K (PK)-resistant PrPSc (PrPres) species are acutely synaptotoxic. Brief exposure to ex vivo PrPSc from two mouse-adapted prion strains (M1000 and MU02) prepared as crude brain homogenates (cM1000 and cMU02) and cell lysates from chronically M1000-infected RK13 cells (MoRK13-Inf) caused significant impairment of hippocampal CA1 region long-term potentiation (LTP), with the LTP disruption approximating that reported during the evolution of murine prion disease. Proof of PrPSc (especially PrPres) species as the synaptotoxic agent was demonstrated by: significant rescue of LTP following selective immuno-depletion of total PrP from cM1000 (dM1000); modestly PK-treated cM1000 (PK+M1000) retaining full synaptotoxicity; and restoration of the LTP impairment when employing reconstituted, PK-eluted, immuno-precipitated M1000 preparations (PK+IP-M1000). Additional detailed electrophysiological analyses exemplified by impairment of post-tetanic potentiation (PTP) suggest possible heightened pre-synaptic vulnerability to the acute synaptotoxicity. This dysfunction correlated with cumulative insufficiency of replenishment of the readily releasable pool (RRP) of vesicles during repeated high-frequency stimulation utilised for induction of LTP. Broadly comparable results with LTP and PTP impairment were obtained utilizing hippocampal slices from PrPC knockout (PrPo/o) mice, with cM1000 serial dilution assessments revealing similar sensitivity of PrPo/o and wild type (WT) slices. Size fractionation chromatography demonstrated that synaptotoxic PrP correlated with PK-resistant species >100kDa, consistent with multimeric PrPSc, with levels of these species >6 ng/ml appearing sufficient to induce synaptic dysfunction. Biochemical analyses of hippocampal slices manifesting acute synaptotoxicity demonstrated reduced levels of multiple key synaptic proteins, albeit with noteworthy differences in PrPo/o slices, while such changes were absent in hippocampi demonstrating rescued LTP through treatment with dM1000. Our findings offer important new mechanistic insights into the synaptic impairment underlying prion disease, enhancing prospects for development of targeted effective therapies. |
| first_indexed | 2024-12-19T10:25:40Z |
| format | Article |
| id | doaj.art-711678d966744eccba3dfa4eaf8d1291 |
| institution | Directory Open Access Journal |
| issn | 1553-7366 1553-7374 |
| language | English |
| last_indexed | 2024-12-19T10:25:40Z |
| publishDate | 2018-08-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Pathogens |
| spelling | doaj.art-711678d966744eccba3dfa4eaf8d12912022-12-21T20:25:55ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742018-08-01148e100721410.1371/journal.ppat.1007214Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species.Simote Totauhelotu FoliakiVictoria LewisDavid Isaac FinkelsteinVictoria LawsonHarold Arthur ColemanMatteo SenesiAbu Mohammed Taufiqual IslamFeng ChenShannon SarrosBlaine RobertsPaul Anthony AdlardSteven John CollinsAlthough misfolding of normal prion protein (PrPC) into abnormal conformers (PrPSc) is critical for prion disease pathogenesis our current understanding of the underlying molecular pathophysiology is rudimentary. Exploiting an electrophysiology paradigm, herein we report that at least modestly proteinase K (PK)-resistant PrPSc (PrPres) species are acutely synaptotoxic. Brief exposure to ex vivo PrPSc from two mouse-adapted prion strains (M1000 and MU02) prepared as crude brain homogenates (cM1000 and cMU02) and cell lysates from chronically M1000-infected RK13 cells (MoRK13-Inf) caused significant impairment of hippocampal CA1 region long-term potentiation (LTP), with the LTP disruption approximating that reported during the evolution of murine prion disease. Proof of PrPSc (especially PrPres) species as the synaptotoxic agent was demonstrated by: significant rescue of LTP following selective immuno-depletion of total PrP from cM1000 (dM1000); modestly PK-treated cM1000 (PK+M1000) retaining full synaptotoxicity; and restoration of the LTP impairment when employing reconstituted, PK-eluted, immuno-precipitated M1000 preparations (PK+IP-M1000). Additional detailed electrophysiological analyses exemplified by impairment of post-tetanic potentiation (PTP) suggest possible heightened pre-synaptic vulnerability to the acute synaptotoxicity. This dysfunction correlated with cumulative insufficiency of replenishment of the readily releasable pool (RRP) of vesicles during repeated high-frequency stimulation utilised for induction of LTP. Broadly comparable results with LTP and PTP impairment were obtained utilizing hippocampal slices from PrPC knockout (PrPo/o) mice, with cM1000 serial dilution assessments revealing similar sensitivity of PrPo/o and wild type (WT) slices. Size fractionation chromatography demonstrated that synaptotoxic PrP correlated with PK-resistant species >100kDa, consistent with multimeric PrPSc, with levels of these species >6 ng/ml appearing sufficient to induce synaptic dysfunction. Biochemical analyses of hippocampal slices manifesting acute synaptotoxicity demonstrated reduced levels of multiple key synaptic proteins, albeit with noteworthy differences in PrPo/o slices, while such changes were absent in hippocampi demonstrating rescued LTP through treatment with dM1000. Our findings offer important new mechanistic insights into the synaptic impairment underlying prion disease, enhancing prospects for development of targeted effective therapies.http://europepmc.org/articles/PMC6101418?pdf=render |
| spellingShingle | Simote Totauhelotu Foliaki Victoria Lewis David Isaac Finkelstein Victoria Lawson Harold Arthur Coleman Matteo Senesi Abu Mohammed Taufiqual Islam Feng Chen Shannon Sarros Blaine Roberts Paul Anthony Adlard Steven John Collins Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species. PLoS Pathogens |
| title | Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species. |
| title_full | Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species. |
| title_fullStr | Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species. |
| title_full_unstemmed | Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species. |
| title_short | Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species. |
| title_sort | prion acute synaptotoxicity is largely driven by protease resistant prpsc species |
| url | http://europepmc.org/articles/PMC6101418?pdf=render |
| work_keys_str_mv | AT simotetotauhelotufoliaki prionacutesynaptotoxicityislargelydrivenbyproteaseresistantprpscspecies AT victorialewis prionacutesynaptotoxicityislargelydrivenbyproteaseresistantprpscspecies AT davidisaacfinkelstein prionacutesynaptotoxicityislargelydrivenbyproteaseresistantprpscspecies AT victorialawson prionacutesynaptotoxicityislargelydrivenbyproteaseresistantprpscspecies AT haroldarthurcoleman prionacutesynaptotoxicityislargelydrivenbyproteaseresistantprpscspecies AT matteosenesi prionacutesynaptotoxicityislargelydrivenbyproteaseresistantprpscspecies AT abumohammedtaufiqualislam prionacutesynaptotoxicityislargelydrivenbyproteaseresistantprpscspecies AT fengchen prionacutesynaptotoxicityislargelydrivenbyproteaseresistantprpscspecies AT shannonsarros prionacutesynaptotoxicityislargelydrivenbyproteaseresistantprpscspecies AT blaineroberts prionacutesynaptotoxicityislargelydrivenbyproteaseresistantprpscspecies AT paulanthonyadlard prionacutesynaptotoxicityislargelydrivenbyproteaseresistantprpscspecies AT stevenjohncollins prionacutesynaptotoxicityislargelydrivenbyproteaseresistantprpscspecies |